Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine vs Olanzapine + Trifluoperazine for Schizophrenia
NCT02704962Phase 4Completed
- Sponsor
- Kaohsiung Municipal Kai-Suan Psychiatric Hospital
- Start
- Jan 2012
- Primary completion
- Feb 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in schizophrenia comparing trifluoperazine plus olanzapine with full-dose olanzapine (2 arms). Primary endpoint: Positive and Negative Syndrome Scale at 6 weeks. Started Jan 2012; status: completed.
02
Drugs
olanzapinetrifluoperazine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02704962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02704962.